Development and clinical application of radiomics in lung cancer

Radiation Oncology

Volumn 12, Issue 1, 2017, Pages

  Chen, Bojiang ^a   Zhang, Rui ^a   Gan, Yuncui ^a   Yang, Lan ^a   Li, Weimin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Lung cancer; Phenotype; Pulmonary nodule; Radiomics

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DATA ANALYSIS; HUMAN; IMAGE RECONSTRUCTION; IMAGE SEGMENTATION; LUNG CANCER; LUNG NODULE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIOLOGY; RADIOMICS; REVIEW; TREATMENT RESPONSE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; LUNG TUMOR; PROCEDURES;

DIAGNOSTIC IMAGING; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LUNG NEOPLASMS;

EID: 85029539428     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/s13014-017-0885-x     Document Type: Review

References (52)

1. Jones PA, Issa J-PJ, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016;17:630-41.
2. Robles AI, Jen J, Harris CC. Clinical Outcomes of TP53 Mutations in Cancers. Cold Spring Harb Perspect Med. 2016; 6.
3. Caswell DR, Swanton C. The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Med. 2017;15:133.
4. Baumann M, Hölscher T, Begg AC. Towards genetic prediction of radiation responses: ESTRO's GENEPI project. Radiother Oncol. 2003;69:121-5.
5. Rutman AM, Kuo MD. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. Eur J Radiol. 2009;70:232-41.
6. Segal E, Sirlin CB, Ooi C, et al. Decoding global gene expression programs in liver cancer by noninvasive imaging. Nat Biotechnol. 2007;25:675-80.
7. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med. 2012;366:883-92.
8. Ghadimi BM, Jo P. Cancer Gene Profiling for Response Prediction. Methods Mol Biol. 2016;1381:163-79. doi: 10.1007/978-1-4939-3204-7_9.
9. Gatenby RA, Grove O, Gillies RJ. Quantitative imaging in cancer evolution and ecology. Radiology. 2013;269:8-14.
10. Burrell RA, McGranahan N, Bartek J, et al. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501:338.
11. Huo D, Hu H, Rhie SK, et al. Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. JAMA Oncol. 2017. doi: 10.1001/jamaoncol.2017.0595.
12. Hartmaier RJ, Albacker L, Chmielecki J et al. High-throughput genomic profiling of adult solid tumors reveals novel insights into cancer pathogenesis. Cancer Res. 2017.
13. Gutierrez ME, Choi K, Lanman RB et al. Genomic Profiling of Advanced Non-Small Cell Lung Cancer in Community Settings: Gaps and Opportunities. Clin Lung Cancer. 2017.
14. Lambin P, Rios-Velazquez E, Leijenaar R, et al. Radiomics: extracting more information from medical images using advanced feature analysis. Eur J Cancer. 2012;48:441-6.
15. Mitra S, Shankar BU. Integrating radio imaging with gene expressions toward a personalized management of cancer. IEEE Trans Human-Mach Syst. 2014;44:664-77.
16. Kumar V, Gu Y, Basu S, et al. Radiomics: the process and the challenges. Magn Reson Imaging. 2012;30:1234-48.
17. Zhao B, Tan Y, Tsai W-Y, et al. Reproducibility of radiomics for deciphering tumor phenotype with imaging. Sci Rep. 2016;6:23428.
18. Mackin D, Fave X, Zhang L, et al. Measuring CT scanner variability of radiomics features. Investig Radiol. 2015;50:757.
19. Oliver JA, Budzevich M, Zhang GG, et al. Variability of image features computed from conventional and respiratory-gated PET/CT images of lung cancer. Transl Oncol. 2015;8:524-34.
20. Huq MS, Fraass BA, Dunscombe PB, et al. The report of task group 100 of the AAPM: application of risk analysis methods to radiation therapy quality management. Med Phys. 2016;43:4209-62.
21. Yang X, Knopp MV. Quantifying tumor vascular heterogeneity with dynamic contrast-enhanced magnetic resonance imaging: a review. J Biomed Biotechnol. 2011;2011:732848.
22. Koh D-M, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. Am J Roentgenol. 2007;188:1622-35.
23. van Velden FH, Kramer GM, Frings V, et al. Repeatability of radiomic features in non-small-cell lung cancer [18F] FDG-PET/CT studies: impact of reconstruction and delineation. Mol Imaging Biol. 2016;18:788-95.
24. El Naqa I. The role of quantitative PET in predicting cancer treatment outcomes. Clin Transl Imaging. 2014;2:305-20.
25. Öllers M, Bosmans G, van Baardwijk A, et al. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning. Radiother Oncol. 2008;87:142-6.
26. Coenen A, Honda O, van der Jagt EJ, et al. Computer-assisted solid lung nodule 3D volumetry on CT: influence of scan mode and iterative reconstruction: a CT phantom study. Jpn J Radiol. 2013;31:677-84.
27. Parmar C, Velazquez ER, Leijenaar R, et al. Robust radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One. 2014;9:e102107.
28. Wibmer A, Hricak H, Gondo T, et al. Haralick texture analysis of prostate MRI: utility for differentiating non-cancerous prostate from prostate cancer and differentiating prostate cancers with different Gleason scores. Eur Radiol. 2015;25:2840-50.
29. Haralick RM, Shanmugam K. Textural features for image classification. IEEE Trans Syst Man Cybern. 1973;6:610-21.
30. Parmar C, Grossmann P, Bussink J, et al. Machine learning methods for quantitative radiomic biomarkers. Sci Rep. 2015;5:13087.
31. Gillies RJ, Kinahan PE, Hricak H. Radiomics: images are more than pictures, they are data. Radiology. 2015;278:563-77.
32. Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.
33. Levy MA, Freymann JB, Kirby JS, et al. Informatics methods to enable sharing of quantitative imaging research data. Magn Reson Imaging. 2012;30:1249-56.
34. Ma J, Wang Q, Ren Y, et al. Automatic lung nodule classification with radiomics approach. In: SPIE medical imaging: International Society for Optics and Photonics; 2016. p. 978906.
35. Hawkins S, Wang H, Liu Y, et al. Predicting malignant nodules from screening CT scans. J Thorac Oncol. 2016;11:2120-8.
36. Godoy MC, Naidich DP. Overview and strategic management of subsolid pulmonary nodules. J Thorac Imaging. 2012;27:240-8.
37. Lee SH, Lee SM, Goo JM, et al. Usefulness of texture analysis in differentiating transient from persistent part-solid nodules (PSNs): a retrospective study. PLoS One. 2014;9:e85167.
38. Chae H-D, Park CM, Park SJ, et al. Computerized texture analysis of persistent part-solid ground-glass nodules: differentiation of preinvasive lesions from invasive pulmonary adenocarcinomas. Radiology. 2014;273:285-93.
39. Wu W, Parmar C, Grossmann P et al. Exploratory study to identify radiomics classifiers for lung cancer histology. Front Oncol. 2016; 6.
40. Lilenbaum RA, Horn LA. Management of EGFR mutation-positive non-small cell lung cancer. J Natl Compr Cancer Netw. 2016;14:672-4.
41. Liu Y, Kim J, Balagurunathan Y, et al. Radiomic features are associated with EGFR mutation status in lung adenocarcinomas. Clinical lung cancer. 2016;17:441-8. e446
42. Weiss GJ, Ganeshan B, Miles KA, et al. Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic. PLoS One. 2014;9:e100244.
43. Yoon HJ, Sohn I, Cho JH, et al. Decoding tumor phenotypes for ALK, ROS1, and RET fusions in lung adenocarcinoma using a radiomics approach. Medicine. 2015;94:e1753.
44. Parmar C, Leijenaar RT, Grossmann P, et al. Radiomic feature clusters and prognostic signatures specific for lung and head & neck cancer. Sci Rep. 2015;5:srep11044.
45. Coroller TP, Grossmann P, Hou Y, et al. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma. Radiother Oncol. 2015;114:345-50.
46. Coroller TP, Agrawal V, Narayan V, et al. Radiomic phenotype features predict pathological response in non-small cell lung cancer. Radiother Oncol. 2016;119:480-6.
47. Mattonen SA, Palma DA, Johnson C, et al. Detection of local cancer recurrence after stereotactic ablative radiation therapy for lung cancer: physician performance versus radiomic assessment. Int J Radiat Oncol Biol Phys. 2016;94:1121-8.
48. Defraene G, van Elmpt W, Crijns W, et al. CT characteristics allow identification of patient-specific susceptibility for radiation-induced lung damage. Radiother Oncol. 2015;117:29-35.
49. Ghobadi G, Wiegman EM, Langendijk JA, et al. A new CT-based method to quantify radiation-induced lung damage in patients. Radiother Oncol. 2015;117:4-8.
50. Moran A, Daly ME, Yip SSF et al. Radiomics-based Assessment of Radiation-induced Lung Injury After Stereotactic Body Radiotherapy. Clin Lung Cancer. 2017. doi: 10.1016/j.cllc.2017.05.014.
51. Li Q, Kim J, Balagurunathan Y et al. Imaging features from pre-treatment CT scans are associated with clinical outcomes in non-small-cell lung cancer patients treated with stereotactic body radiotherapy. Med Phys. 2017.
52. Huynh E, Coroller TP, Narayan V, et al. Associations of radiomic data extracted from static and respiratory-gated CT scans with disease recurrence in lung cancer patients treated with SBRT. PLoS One. 2017;12:e0169172.